Publications in Scientific Journals:
P. Farahmand, F. Marin, F. Hawkins, R. Möricke, J.D. Ringe, C.C. Glüer, N. Papaioannu, S. Minisola, G. Martínez, J.M. Nolla, C. Niedhart, N. Guañabens, R. Nuti, E. Martín-Mola, F. Thomasius, J. Peña, C. Graeff, G. Kapetanos, H. Petto, A. Gentzel, A.G. Reisinger, P.K. Zysset:
"Early Changes in Biochemical Markers of Bone Formation During Teriparatide Therapy Correlate with Improvements in Vertebral Strength in Men with Glucocorticoid-Induced Osteoporosis";
Osteoporosis International,
24
(2013),
12;
2971
- 2981.
English abstract:
Changes of the bone formation marker PINP correlated positively with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis (GIO) who received 18-month treatment with teriparatide, but not with risedronate. These results support the use of PINP as a surrogate marker of bone strength in GIO patients treated with teriparatide.
"Official" electronic version of the publication (accessed through its Digital Object Identifier - DOI)
http://dx.doi.org/10.1007/s00198-013-2379-5
Created from the Publication Database of the Vienna University of Technology.